Agilent Technologies, Inc. (A)

Agilent Technologies, Inc. (A) Stock Price: $135.48+2.79 (+2.10%)

The total return cagr for Agilent Technologies, Inc. (A) stock is 16.79% over the past 12 months. The 3 year average growth rate is 6.11% and the 5 year cagr is -0.02%. Total return includes dividends reinvested.

The closing share price for Agilent Technologies, Inc. (A) stock was $135.48 for Tuesday, June 9, 2026, up +2.10% from the previous day.

A Price Chart

End-of-day pricesAdvanced chart →

A$135.48▲ 16.70%as of Jun 9, 2026

A Key Metrics

See All Metrics

LAST CLOSE PRICE

$135.48

52-WEEK RANGE

$108.35 - $160.27

BETA

1.26

% FROM 52W HIGH

-15.47%

MARKET CAP

$38.26B

DIVIDEND YIELD

0.55%

PE RATIO

27.20

PE RATIO (FWD)

20.55

REVENUE TTM

$7.23B

NET INCOME TTM

$1.41B

NET PROFIT MARGIN TTM

18.75%

TTM TOTAL RETURN

+16.79%

3Y TOTAL RETURN

+6.11%

5Y TOTAL RETURN

-0.02%

Price CAGR

Total Return CAGR

Revenue CAGR

Net Income CAGR

EPS CAGR

Dividends CAGR

A Earnings Preview

Next Earnings Date

Aug 26, 2026

78 days away

EPS Estimate

1.49

Revenue Est.

$1.84B

Last Quarter Results

EPS

$1.49

vs Estimate

$1.41

Beat

Revenue

$1.83B

vs Estimate

$1.80B

Beat

A Analyst Ratings

Consensus Rating

Buy

Based on 16 analysts

Strong Buy

Buy

Hold

Sell

Strong Sell

Average Price Target

$161.00

+18.8% upside

Low

$144.00

Current

$135.48

High

$185.00

A Analyst Estimates

Forward P/E: 20.55

Earnings Per Share (EPS) Estimates

Quarterly

Period	Low	Avg	High	# Analysts
Q1 2027	N/A	$1.50	N/A	4
Q2 2027	N/A	$1.60	N/A	4
Q3 2027	N/A	$1.63	N/A	4
Q4 2027	N/A	$1.84	N/A	4

Annual

Period	Low	Avg	High	# Analysts
FY 2027	N/A	$6.59	N/A	11
FY 2028	N/A	$7.29	N/A	6

Revenue Estimates

Quarterly

Period	Low	Avg	High	# Analysts
Q1 2027	N/A	$1.91B	N/A	4
Q2 2027	N/A	$1.94B	N/A	4
Q3 2027	N/A	$1.95B	N/A	4
Q4 2027	N/A	$2.08B	N/A	4

Annual

Period	Low	Avg	High	# Analysts
FY 2027	N/A	$7.88B	N/A	11
FY 2028	N/A	$8.38B	N/A	6

Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.

A Competitors' Key Metrics

Stock	Market Cap	Close Price	Price Change	TTM Total Return	5Y CAGR	10Y CAGR
1A	$38.26B	$135.48	+2.10%	+16.79%	-0.02%	+12.25%

A Charts

Valuation Charts

Performance Charts

Dividend Charts

CAGR Charts

Financial Statement Charts

Other Charts

About Agilent Technologies, Inc.

Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.

Santa Clara, CA

17,900 employees

www.agilent.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Padraig McDonnell

View full financials